PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32060993-3	2020	We characterized inhibition of human CYP1A1, CYP1A2 and CYP1B1 enzymes by the novel inhibitor N-(3,5-dichlorophenyl) cyclopropanecarboxamide (DCPCC) and alpha-naphthoflavone (ANF).	cyclopropanecarboxamide	94-140	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	45-51	
32060993-3	2020	We characterized inhibition of human CYP1A1, CYP1A2 and CYP1B1 enzymes by the novel inhibitor N-(3,5-dichlorophenyl) cyclopropanecarboxamide (DCPCC) and alpha-naphthoflavone (ANF).	cyclopropanecarboxamide	142-147	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	45-51	
32060993-4	2020	Depending on substrate, IC50 values of DCPCC for CYP1A1 or CYP1B1 were 10-95 times higher than for CYP1A2.	cyclopropanecarboxamide	39-44	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	99-105	
32060993-5	2020	IC50 of DCPCC for CYP1A2 was 100-fold lower than for enzymes in CYP2 and CYP3 families.	cyclopropanecarboxamide	8-13	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	18-24	
32060993-7	2020	DCPCC was a mixed type inhibitor of CYP1A2.	cyclopropanecarboxamide	0-5	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	36-42	
32060993-11	2020	We conclude that DCPCC is a more selective inhibitor for CYP1A2 than ANF.	cyclopropanecarboxamide	17-22	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	57-63	
32060993-12	2020	DCPCC is a candidate structure to modulate CYP1A2 mediated metabolism of procarcinogens and anticancer drugs.	cyclopropanecarboxamide	0-5	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	43-49